Results 271 to 280 of about 134,020 (288)
Some of the next articles are maybe not open access.
Synthesis, X-ray crystallographic study, pharmacology and docking of hydrazinyl thiazolyl coumarins as dengue virus NS2B/NS3 serine protease inhibitors
, 2018 Samina Khan Yusufzai, Hasnah Osman, Mohammad Shaheen Khan, Basma M. Abd Razik, Suriyati Mohamad, Othman Sulaiman, Jualang Azlan Gansau, Norhaniza Johansah, Mohammed Oday Ezzat, Thaigarajan Parumasivam, Mohd Mustaqim Rosli, Ibrahim Abdul Razak +11 moreopenalex +1 more sourceIndinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains
, 2002 Yuan Cheng, Fengqi Zhang, Thomas A. Rano, Zhijian Lu, William A. Schleif, Lori J. Gabryelski, David B. Olsen, Mark W. Stahlhut, Carrie A. Rutkowski, Jiunn H. Lin, Lixia Jin, Emilio A. Emini, Kevin T. Chapman, James R. Tata +13 moreopenalex +1 more sourceStructure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics
, 2003 Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore Johnson, Hua Ye, H. T. Luu, Sylvie K. Sakata, Edward L. Brown, Fausto C. Maldonado, Tove Tuntland, Caroline A. Lee, Shella A. Fuhrman, L S Zalman, Amy K. Patick, David A. Matthews, Xinglin Wu, Ming Guo, Bennett C. Borer, Naresh K. Nayyar, Terence J. Moran, Lijian Chen, Paul A. Rejto, Peter W. Rose, Mark C. Guzman, Elena Z. Dovalsantos, Steven Lee, Kevin F. McGee, Michael Mohajeri, Andreas Liese, Junhua Tao, Maha Kosa, Bo Liu, Minerva Batugo, Jean-Paul R. Gleeson, Zhenping Wu, Jia Liu, James W. Meador, Rose Ann Ferre +37 moreopenalex +1 more source